|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
30.400 +0.650 (+2.185%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 10,266,288 | 37.918% | 7,443,770 | 5,133,597 | 3,757,160 | 2,908,123 | |
| Cost of Sales | (6,517,012) | 36.576% | (4,771,726) | (3,217,484) | (2,425,459) | (1,960,073) | |
| Gross Profit | 3,749,276 | 40.315% | 2,672,044 | 1,916,113 | 1,331,701 | 948,050 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (21,157) | 106.028% | (10,269) | (14,823) | (5,495) | (8,886) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (33,851) | -- | 71,845 | (24,565) | (7,303) | (1,132) | |
| Profit / (Loss) before Taxation | 1,666,391 | -12.800% | 1,910,996 | 1,319,370 | 632,550 | 395,944 | |
| Taxation | (314,254) | 8.021% | (290,919) | (172,378) | (101,878) | (60,101) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 22,467 | -45.138% | 40,952 | 25,391 | 16,518 | 199 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,374,604 | -17.244% | 1,661,029 | 1,172,383 | 547,190 | 336,042 | |
| Net Finance Costs / (Income) | 132,099 | 607.698% | 18,666 | (50,210) | 72,862 | 81,998 | |
| Depreciation & Amortisation | 766,063 | 32.612% | 577,673 | 438,016 | 374,582 | 315,920 | |
| Directors' Emoluments | -- | -- | 21,653 | 13,637 | 8,963 | 8,373 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 116.250 | -- | 139.880 | 98.833 | 55.227 | 37.927 |
| DPS (cts) | 30.000 | -- | 30.000 | 20.000 | 10.000 | -- |
| Dividend Payout Ratio (%) | 25.806% | -- | 21.447% | 20.236% | 18.107% | -- |
| Cash flow per share ($) | -- | -- | 1.733 | 1.390 | 1.421 | 1.339 |
| NBV per share ($) | 8.690 | -- | 8.336 | 7.444 | 6.518 | -- |
| Remarks: | Real time quote last updated: 02/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,374,604 |
| %Change | -17.244% |
| EPS / (LPS) | RMB 1.163 |
| NBV Per Share (¥) | RMB 8.690 |